HOME | PRESS RELEASES | HOW TO ORDER | CONTACT US | CAREERS | Japanese

Population PK Modeling and Simulation

FDA in its Critical Path Initiative is increasingly advocating the use of pharmaco-statistical models to support improved drug development decision-making. Pharsight scientists offer expertise in all aspects of sparse data analysis:

  • PK/PD modeling of sparse and rich data
  • Model discrimination and validation together with Monte Carlo simulation
  • Sparse sampling strategies
  • Population PK/PD analyses
  • Special populations: pediatrics
  • Parametric and nonparametric population PK/PD analyses